These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36617789)

  • 1. A Child with Refractory and Relapsing Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Myopathy: Case-Based Review.
    Sener S; Batu ED; Sari S; Kasap Cuceoglu M; Yildiz AE; Talim B; Aydingoz U; Ozen S; Haliloglu G
    J Neuromuscul Dis; 2023; 10(2):279-291. PubMed ID: 36617789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review.
    Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P
    Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 81-year old man of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with lung adenocarcinoma cancer].
    Yamanaka N; Sato R; Oishi M; Shimizu F; Koga M; Hoshii Y; Kanda T
    Rinsho Shinkeigaku; 2021 Jul; 61(7):456-460. PubMed ID: 34148931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
    Yamaguchi T; Matsunaga A; Ikawa M; Shirafuji N; Nishino I; Hamano T
    Rinsho Shinkeigaku; 2017 Mar; 57(3):118-123. PubMed ID: 28228619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis.
    Sasaki R; Yunoki T; Nakano Y; Fukui Y; Takemoto M; Morihara R; Katsuyama E; Nishino I; Yamashita T
    Neuromuscul Disord; 2023 Feb; 33(2):183-186. PubMed ID: 36652875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-HMGCR immune-mediated necrotizing myopathy: A case report].
    Zhang YJ; Ma JY; Liu XY; Zheng DF; Zhang YS; Li XG; Fan DS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):558-562. PubMed ID: 37291935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series.
    Joseph VMK; Rose EC; Edwards CJ; Lloyd M; Amar SK; Wheeler RD; Forster T; Smith KA; Eren E; Hughes R; Hajela V; Kiely PDW
    Clin Exp Rheumatol; 2022 Feb; 40(2):298-303. PubMed ID: 35200125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical presentation of anti-HMGCR myopathy.
    Karna R; Singh R; Marshall C; Johnston A
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34544705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
    Khan F; Brady S; Kuttikat A
    Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.
    Liang WC; Wang CH; Chen WZ; Kuo YT; Lin HF; Suzuki S; Nishino I; Jong YJ
    Kaohsiung J Med Sci; 2020 Aug; 36(8):649-655. PubMed ID: 32666706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.
    Munekane A; Ohsawa Y; Okubo M; Nagai T; Nishimura H; Nishino I; Sunada Y
    Intern Med; 2023 May; 62(9):1345-1349. PubMed ID: 36130887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy.
    Sharf K; Do T; Ghetie D; Choi D; Chahin N
    Arthritis Care Res (Hoboken); 2024 Nov; 76(11):1584-1592. PubMed ID: 39054727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
    Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
    Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
    Hama Y; Mori-Yoshimura M; Komaki H; Suzuki S; Kohsaka H; Nishino I; Takahashi Y
    Rinsho Shinkeigaku; 2017 Oct; 57(10):567-572. PubMed ID: 28966227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child.
    Mohassel P; Foley AR; Donkervoort S; Fequiere PR; Pak K; Bönnemann CG; Mammen AL
    Muscle Nerve; 2017 Dec; 56(6):1177-1181. PubMed ID: 28066895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy.
    Suárez B; Jofré J; Lozano-Arango A; Ortega X; Diaz J; Calcagno G; Bevilacqua JA; Castiglioni C
    Neuromuscul Disord; 2020 Jun; 30(6):503-509. PubMed ID: 32518057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.